Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965701166> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1965701166 endingPage "1189" @default.
- W1965701166 startingPage "1184" @default.
- W1965701166 abstract "While hormone receptor values are extremely valuable in breast cancer management, many variables leading to falsely negative receptor results should be considered before clinical decision making in the setting of metastatic disease. At the Papanicolaou Comprehensive Cancer Center in Miami, Florida 271 patients with metastatic breast cancer received tamoxifen over a 4-year period. Only 40 of the 204 patients (19.6%) with available estrogen receptor assay information had pretreatment receptor values classically considered receptor-poor. While four patients had inevaluable tamoxifen trials and 12 patients had compassionate use in end-stage situations, 24 patients received tamoxifen therapy in the face of receptor-poor values because of clinical or histopathological correlates suggesting the possibility of false negative assay results. Six of 36 evaluable patients (16.6%), including those treated on compassionate grounds, responded to tamoxifen, while 6 of 24 more highly selected patients (25%) responded. Response durations in these six patients were 11, 12, 28, 28+, 49, and 51 months, respectively; two of these six also had significant, objective tamoxifen withdrawal responses of 9 and 14 months. Based on these results, it is urged that receptor values are studied and integrated with classical clinical and histopathologic variables before making a clinical decision so that patients with receptor-poor assay results are not prematurely labeled hormonally unresponsive." @default.
- W1965701166 created "2016-06-24" @default.
- W1965701166 creator A5007386275 @default.
- W1965701166 creator A5009555227 @default.
- W1965701166 creator A5012086533 @default.
- W1965701166 creator A5086894399 @default.
- W1965701166 date "1987-09-15" @default.
- W1965701166 modified "2023-10-18" @default.
- W1965701166 title "Response to tamoxifen in estrogen receptor‐poor metastatic breast cancer" @default.
- W1965701166 cites W1968951899 @default.
- W1965701166 cites W1983649348 @default.
- W1965701166 cites W1999256930 @default.
- W1965701166 cites W2033821687 @default.
- W1965701166 cites W2058681718 @default.
- W1965701166 cites W2063142284 @default.
- W1965701166 cites W2169976724 @default.
- W1965701166 cites W2215157437 @default.
- W1965701166 cites W2918420512 @default.
- W1965701166 cites W32801203 @default.
- W1965701166 doi "https://doi.org/10.1002/1097-0142(19870915)60:6<1184::aid-cncr2820600605>3.0.co;2-#" @default.
- W1965701166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3304611" @default.
- W1965701166 hasPublicationYear "1987" @default.
- W1965701166 type Work @default.
- W1965701166 sameAs 1965701166 @default.
- W1965701166 citedByCount "9" @default.
- W1965701166 countsByYear W19657011662012 @default.
- W1965701166 countsByYear W19657011662014 @default.
- W1965701166 crossrefType "journal-article" @default.
- W1965701166 hasAuthorship W1965701166A5007386275 @default.
- W1965701166 hasAuthorship W1965701166A5009555227 @default.
- W1965701166 hasAuthorship W1965701166A5012086533 @default.
- W1965701166 hasAuthorship W1965701166A5086894399 @default.
- W1965701166 hasConcept C121608353 @default.
- W1965701166 hasConcept C126322002 @default.
- W1965701166 hasConcept C143998085 @default.
- W1965701166 hasConcept C23589133 @default.
- W1965701166 hasConcept C2775930923 @default.
- W1965701166 hasConcept C2777176818 @default.
- W1965701166 hasConcept C29456083 @default.
- W1965701166 hasConcept C530470458 @default.
- W1965701166 hasConcept C535046627 @default.
- W1965701166 hasConcept C71924100 @default.
- W1965701166 hasConcept C84606932 @default.
- W1965701166 hasConcept C98717036 @default.
- W1965701166 hasConceptScore W1965701166C121608353 @default.
- W1965701166 hasConceptScore W1965701166C126322002 @default.
- W1965701166 hasConceptScore W1965701166C143998085 @default.
- W1965701166 hasConceptScore W1965701166C23589133 @default.
- W1965701166 hasConceptScore W1965701166C2775930923 @default.
- W1965701166 hasConceptScore W1965701166C2777176818 @default.
- W1965701166 hasConceptScore W1965701166C29456083 @default.
- W1965701166 hasConceptScore W1965701166C530470458 @default.
- W1965701166 hasConceptScore W1965701166C535046627 @default.
- W1965701166 hasConceptScore W1965701166C71924100 @default.
- W1965701166 hasConceptScore W1965701166C84606932 @default.
- W1965701166 hasConceptScore W1965701166C98717036 @default.
- W1965701166 hasIssue "6" @default.
- W1965701166 hasLocation W19657011661 @default.
- W1965701166 hasLocation W19657011662 @default.
- W1965701166 hasOpenAccess W1965701166 @default.
- W1965701166 hasPrimaryLocation W19657011661 @default.
- W1965701166 hasRelatedWork W1437839308 @default.
- W1965701166 hasRelatedWork W1965701166 @default.
- W1965701166 hasRelatedWork W2037999876 @default.
- W1965701166 hasRelatedWork W2103643613 @default.
- W1965701166 hasRelatedWork W2131308508 @default.
- W1965701166 hasRelatedWork W2161109798 @default.
- W1965701166 hasRelatedWork W2357456301 @default.
- W1965701166 hasRelatedWork W2507695150 @default.
- W1965701166 hasRelatedWork W4205578220 @default.
- W1965701166 hasRelatedWork W2309772632 @default.
- W1965701166 hasVolume "60" @default.
- W1965701166 isParatext "false" @default.
- W1965701166 isRetracted "false" @default.
- W1965701166 magId "1965701166" @default.
- W1965701166 workType "article" @default.